Investigational vaccine and immune therapy work well together to fight breast cancer

[News]

A vaccine for HER2-positive breast cancers that is being tested in a clinical trial at Duke Cancer Institute is part of an effective, two-drug strategy for enlisting the immune system to fight tumors, according to a Duke-led study in Clinical Cancer Research, a journal of the American Association for Cancer Research.

More... (https://www.news-medical.net/news/20200730/Investigational-vaccine-and-immune-therapy-work-well-together-to-fight-breast-cancer.aspx)